ADVANCING IMMUNOTHERAPY in ONCOLOGY, created in 2008 (United States), from 496 sister brands and 17477 competing brands. The ADVANCING IMMUNOTHERAPY in ONCOLOGY brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. The sector of ADVANCING IMMUNOTHERAPY in ONCOLOGY is Drug Manufacturers.
News from the brand ADVANCING IMMUNOTHERAPY in ONCOLOGY
Recent tweets
BRISTOL-MYERS SQUIBB COMPANY
(ADVANCING IMMUNOTHERAPY in ONCOLOGY)
.
All news 
BRISTOL-MYERS SQUIBB COMPANY
(ADVANCING IMMUNOTHERAPY in ONCOLOGY)
Recent tweets
BRISTOL-MYERS SQUIBB COMPANY
(ADVANCING IMMUNOTHERAPY in ONCOLOGY)
.
Stock exchange: More information on BRISTOL-MYERS SQUIBB COMPANY
(ADVANCING IMMUNOTHERAPY in ONCOLOGY)
